0001193125-22-024616 Sample Contracts
POSEIDA THERAPEUTICS, INC. SEVERANCE AND CHANGE IN CONTROL PLAN AMENDED AND RESTATED PARTICIPATION AGREEMENTSeverance and Change in Control Plan • February 1st, 2022 • Poseida Therapeutics, Inc. • Biological products, (no disgnostic substances)
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • February 1st, 2022 • Poseida Therapeutics, Inc. • Biological products, (no disgnostic substances) • California
This AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (“Agreement”) is entered into effective February 1, 2022 (“Effective Date”), by and between Mark Gergen (“Executive”) and Poseida Therapeutics, Inc. (“Company”).
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • February 1st, 2022 • Poseida Therapeutics, Inc. • Biological products, (no disgnostic substances) • California
This AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (“Agreement”) is entered into effective February 1, 2022 (“Effective Date”), by and between Eric Ostertag (“Executive”) and Poseida Therapeutics, Inc. (“Company”).